Shows
MicrobiosLa Inteligencia Artificial y Su Rol en la Medicina ContemporáneaLa inteligencia artificial (IA) está siendo utilizada en múltiples áreas de la vida cotidiana. Su aplicación en medicina podría cambiar las estrategias utilizadas para el diagnóstico y tratamiento de las enfermedades. Invitado: Dra. Lilian Abbo Temas tratados: Definición de la inteligencia artificial Aplicación actual de la IA Futuro de la IA en el área de la medicina 2024-03-0848 min
The ASHE PodcastEpisode 9: Blazing Trails and Building a Global ID Family with Lilian AbboJoin hosts Gonzalo Bearman and Priya Nori as the interview today's esteemed guest, Lilian Abbo. They will be discussing Dr. Abbo's recent Careers article in ASHE. Listen to learn more about Dr. Abbo's professional path and the personal drivers of her success as well as the mentorship relationships throughout her career. After listening, be sure to go to Cambridge.org/ashe to read their full manuscripts and learn more.2023-10-0640 min
Editors in ConversationArtificial Intelligence and Infectious DiseasesArtificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures. AAC recently published a commentary on the impact of AI in infectious diseases and we have a conversation with the lead author of the manuscript and a expert guest who is applying these concepts in real time. Topics discussed: Basic concepts of AI an...2023-09-0938 min
Let's Talk IDPresident's Podcast: Fostering the next generation of Hispanic leadersThe number of foreign medical graduates interested in infectious diseases is increasing. IDSA President Carlos del Rio, MD, FIDSA speaks to fellow Hispanic board members Lilian Abbo, MD, FIDSA, Cesar Arias, MD, MS, PhD, FIDSA and Max Brito, MD, MPH, FIDSA about their journeys to ID as foreign medical graduates and how to foster the next generation of Hispanic ID leaders. 2023-08-0827 min
CCO Infectious Disease PodcastAll Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial ResistanceIn this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:Diverse strains and virulence factors associated with invasive diseaseAntimicrobial resistance profiles seen in clinical practiceVarious disease manifestationsPrevalence and burden of invasive infectionsPopulations at riskRisk factors for multidrug-resistant strainsEmerging vaccine technologiesActive clinical trials Benefits of vaccines and the challenges associated with developmentImportance of antimicrobial stewardship and potential role of vaccines to reduce antimicrobial resistanceProgram Director: Lilian Abbo, MD, FIDSAAssociate Chief Medical Officer in Infectious Diseases2022-10-181h 18
CCO Infectious Disease PodcastHABP/VABP and Gram-Negative Resistance: Pathways to Early Effective TherapyIn this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including:Epidemiology and burden of nosocomial bacterial pneumoniaPatient-specific risk factors for MDR pathogensImproving outcomes with the use of antibiogramsRecommended empiric therapy for clinically suspected VABPAntimicrobial resistance in HABP/VABPAlgorithms for gram-negative organism antibiotic-susceptibility testingUsing rapid diagnostic tests for HABP/VABPNew antimicrobial agents for MDR gram-negative infections with discussion of the 2021 IDSA guidance, and the following studies:ASPECT-NP: ceftolozane/tazobactam vs meropenemREPROVE: ceftazidime/avibactam vs meropenemRESTORE-IMI-1 imipenem/cilastatin/relebactam vs colistin + imipenemRESTORE-IMI-2: imipenem/cilastatin/relebactam vs...2022-03-151h 41
Let's Talk IDRecognizing Hispanic Heritage MonthIDSA President-Elect Carlos del Rio, MD, FIDSA moderates a discussion with Lilian Abbo, MD, FIDSA, Angelica Cifuentes Kottkamp, MD, and Robert Rodriguez, MD on the impact the COVID-19 pandemic has had on the Latinx community, cultural nuances and practices for engaging in an effective and culturally competent patient-provider relationship and the progress made in developing pathways for the next generation of Hispanic physicians.2021-10-0947 min